Updated Outcomes from the Historical Control Study SCHOLAR-3 Contextualizing ZUMA-3 Results of Brexucabtagene Autoleucel (KTE-X19) in Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL)

被引：2

作者：

Shah, Bijal D. ^{[1
]}

Ghobadi, Armin ^{[2
]}

Oluwole, Olalekan O. ^{[3
]}

Logan, Aaron C. ^{[4
]}

Boissel, Nicolas ^{[5
]}

Cassaday, Ryan D. ^{[6
]}

Leguay, Thibaut ^{[7
]}

Bishop, Michael R. ^{[8
]}

Topp, Max S. ^{[9
]}

Tzachanis, Dimitrios ^{[10
]}

O'Dwyer, Kristen M. ^{[11
]}

Arellano, Martha L. ^{[12
]}

Lin, Yi ^{[13
]}

Baer, Maria R. ^{[14
]}

Schiller, Gary J. ^{[15
]}

Park, Jae H. ^{[16
]}

Subklewe, Marion ^{[17
]}

Abedi, Mehrdad ^{[18
]}

Minnema, Monique C. ^{[19
]}

Wierda, William G. ^{[20
]}

DeAngelo, Daniel J. ^{[21
]}

Stiff, Patrick ^{[22
]}

Jeyakumar, Deepa ^{[23
]}

Dong, Jinghui ^{[24
]}

Adhikary, Sabina ^{[24
]}

Zhou, Lang ^{[24
]}

Schuberth, Petra C. ^{[24
]}

Faghmous, Imi ^{[24
]}

Masouleh, Behzad Kharabi ^{[24
]}

Houot, Roch ^{[25
,26
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[2] Washington Univ, Sch Med, St Louis, MO USA

[3] Vanderbilt Univ, Canc Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA

[4] UCSF Med Ctr, San Francisco, CA USA

[5] Hop St Louis, Paris, France

[6] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA

[7] CHU Bordeaux, Serv Hematol Clin & Therapie Cellulaire, Hop Haut Leveque, Bordeaux, France

[8] Univ Chicago Med, Chicago, IL USA

[9] Univ Klinikum WUrzburg, Med Klin & Poliklin 2, Wurzburg, Germany

[10] Univ Calif San Diego, San Diego, CA 92103 USA

[11] Univ Rochester, Wilmot Canc Inst, Rochester, NY USA

[12] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[13] Mayo Clin, Div Hematol, Rochester, MN USA

[14] Univ Maryland, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA

[15] UCLA, David Geffen Sch Med, Los Angeles, CA 90095 USA

[16] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[17] Ludwig Maximilians Univ Munchen, Munich, Germany

[18] Univ Calif Davis, Davis Comprehens Canc Ctr, Sacramento, CA 95817 USA

[19] Univ Med Ctr Utrecht, Behalf HOVON LLPC, Utrecht, Netherlands

[20] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[21] Dana Farber Canc Inst, Boston, MA USA

[22] Loyola Univ Chicago, Stritch Sch Med, Maywood, IL USA

[23] Univ Calif Irvine, Irvine Med Ctr, Orange, CA 92668 USA

[24] Kite, Santa Monica, CA USA

[25] Univ Rennes, INSERM, CHU Rennes, Rennes, France

[26] EFS, Rennes, France

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-158248

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3158 / 3161

页数：4

共 50 条

[1] 2-year update of KTE-X19 in adults with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) in ZUMA-3
Shah, Bijal D.
Ghobadi, Armin
Oluwole, Olalekan O.
Logan, Aaron C.
Boissel, Nicolas
Cassaday, Ryan D.
Forcade, Edouard
Bishop, Michael R.
Topp, Max S.
Tzachanis, Dimitrios
O'Dwyer, Kristen M.
Arellano, Martha L.
Lin, Yi
Baer, Maria R.
Schiller, Gary J.
Zhou, Lang
Schuberth, Petra C.
Masouleh, Behzad Kharabi
Houot, Roch
ANNALS OF ONCOLOGY, 2023, 34 : S1389 - S1389
[2] Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study
Shah, Bijal D.
Ghobadi, Armin
Oluwole, Olalekan O.
Logan, Aaron C.
Boissel, Nicolas
Cassaday, Ryan D.
Leguay, Thibaut
Bishop, Michael R.
Topp, Max S.
Tzachanis, Dimitrios
O'Dwyer, Kristen M.
Arellano, Martha L.
Lin, Yi
Baer, Maria R.
Schiller, Gary J.
Park, Jae H.
Subklewe, Marion
Abedi, Mehrdad
Minnema, Monique C.
Wierda, William G.
DeAngelo, Daniel J.
Stiff, Patrick
Jeyakumar, Deepa
Dong, Jinghui
Adhikary, Sabina
Zhou, Lang
Schuberth, Petra C.
Faghmous, Imi
Masouleh, Behzad Kharabi
Houot, Roch
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
[3] Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study
Bijal D. Shah
Armin Ghobadi
Olalekan O. Oluwole
Aaron C. Logan
Nicolas Boissel
Ryan D. Cassaday
Thibaut Leguay
Michael R. Bishop
Max S. Topp
Dimitrios Tzachanis
Kristen M. O’Dwyer
Martha L. Arellano
Yi Lin
Maria R. Baer
Gary J. Schiller
Jae H. Park
Marion Subklewe
Mehrdad Abedi
Monique C. Minnema
William G. Wierda
Daniel J. DeAngelo
Patrick Stiff
Deepa Jeyakumar
Jinghui Dong
Sabina Adhikary
Lang Zhou
Petra C. Schuberth
Imi Faghmous
Behzad Kharabi Masouleh
Roch Houot
Journal of Hematology & Oncology, 15
[4] Long-term survival outcomes of patients (pts) with relapsed or refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) treated with brexucabtagene autoleucel (brexu-cel) in ZUMA-3
Oluwole, Olalekan O.
Ghobadi, Armin
Cassaday, Ryan Daniel
Park, Jae H.
Houot, Roch
Logan, Aaron
Boissel, Nicolas
Leguay, Thibaut
Bishop, Michael Russell
Topp, Max S.
O'Dwyer, Kristen M.
Baer, Maria R.
Schiller, Gary J.
Abedi, Mehrdad
Minnema, Monique C.
Stiff, Patrick J.
Zhou, Lang
Siddiqi, Rubina
Khalid, Rita Damico
Shah, Bijal D.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[5] Cost-Effectiveness of KTE-X19 for Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) in the United States
Shah, Bijal
Smith, Nathaniel
Raad, Angie
Feng, Chaoling
Castaigne, Gab
Masouleh, Behzad Kharabi
Malone, Daniel
Bishop, Michael
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S272 - S273
[6] Phase 2 results of the ZUMA-3 study evaluating KTE-X19, an anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL)
Topp, M. S.
Shah, B. D.
Ghobadi, A.
Oluwole, O. O.
Logan, A. C.
Boissel, N.
Cassaday, R. D.
Forcade, E.
Bishop, M. R.
Tzachanis, D.
O'Dwyer, K. M.
Arellano, M. L.
Lin, Y.
Baer, M. R.
Schiller, G. J.
Dong, J.
Shen, T.
Milletti, F.
Masouleh, Kharabi B.
Houot, R.
ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 16 - 16
[7] Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3
Shah, Bijal D.
Cassaday, Ryan D.
Park, Jae H.
Houot, Roch
Logan, Aaron C.
Boissel, Nicolas
Leguay, Thibaut
Bishop, Michael R.
Topp, Max S.
O'Dwyer, Kristen M.
Tzachanis, Dimitrios
Arellano, Martha L.
Lin, Yi
Baer, Maria R.
Schiller, Gary J.
Subklewe, Marion
Abedi, Mehrdad
Minnema, Monique C.
Wierda, William G.
Deangelo, Daniel J.
Stiff, Patrick
Jeyakumar, Deepa
Mao, Daqin
Adhikary, Sabina
Zhou, Lang
Hadjivassileva, Tsveta
Khalid, Rita Damico
Ghobadi, Armin
Oluwole, Olalekan O.
LEUKEMIA, 2025,
[8] Phase 2 results of the ZUMA-3 study evaluating KTE-X19, an anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, in adult patients (pts) with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL).
Shah, Bijal D.
Ghobadi, Armin
Oluwole, Olalekan O.
Logan, Aaron
Boissel, Nicolas
Cassaday, Ryan Daniel
Forcade, Edouard
Bishop, Michael Russell
Topp, Max S.
Tzachanis, Dimitrios
O'Dwyer, Kristen M.
Arellano, Martha Lucia
Lin, Yi
Baer, Maria R.
Schiller, Gary J.
Dong, Jinghui
Shen, Tong
Milletti, Francesca
Masouleh, Behzad Kharabi
Houot, Roch
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[9] Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3
Shah, Bijal D.
Cassaday, Ryan D.
Park, Jae H.
Houot, Roch
Oluwole, Olalekan O.
Logan, Aaron C.
Boissel, Nicolas
Leguay, Thibaut
Bishop, Michael R.
Topp, Max S.
Tzachanis, Dimitrios
O'Dwyer, Kristen M.
Arellano, Martha L.
Lin, Yi
Baer, Maria R.
Schiller, Gary J.
Subklewe, Marion
Abedi, Mehrdad
Minnema, Monique C.
Wierda, William G.
DeAngelo, Daniel J.
Stiff, Patrick J.
Jeyakumar, Deepa
Mao, Daqin
Adhikary, Sabina
Zhou, Lang
Schuberth, Petra C.
Damico Khalid, Rita
Ghobadia, Armin
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (08)
[10] KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
Shah, Bijal D.
Ghobadi, Armin
Oluwole, Olalekan O.
Logan, Aaron C.
Boissel, Nicolas
Cassaday, Ryan D.
Leguay, Thibaut
Bishop, Michael R.
Topp, Max S.
Tzachanis, Dimitrios
O'Dwyer, Kristen M.
Arellano, Martha L.
Lin, Yi
Baer, Maria R.
Schiller, Gary J.
Park, Jae H.
Subklewe, Marion
Abedi, Mehrdad
Minnema, Monique C.
Wierda, William G.
DeAngelo, Daniel J.
Stiff, Patrick
Jeyakumar, Deepa
Feng, Chaoling
Dong, Jinghui
Shen, Tong
Milletti, Francesca
Rossi, John M.
Vezan, Remus
Masouleh, Behzad Kharabi
Houot, Roch
LANCET, 2021, 398 (10299): : 491 - 502

← 1 2 3 4 5 →